GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Applied DNA Sciences Inc (FRA:UDJ) » Definitions » Cyclically Adjusted PS Ratio

Applied DNA Sciences (FRA:UDJ) Cyclically Adjusted PS Ratio : 0.04 (As of May. 26, 2024)


View and export this data going back to 2001. Start your Free Trial

What is Applied DNA Sciences Cyclically Adjusted PS Ratio?

As of today (2024-05-26), Applied DNA Sciences's current share price is €4.66. Applied DNA Sciences's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was €125.00. Applied DNA Sciences's Cyclically Adjusted PS Ratio for today is 0.04.

The historical rank and industry rank for Applied DNA Sciences's Cyclically Adjusted PS Ratio or its related term are showing as below:

FRA:UDJ' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.01   Med: 5.21   Max: 85
Current: 0.01

During the past years, Applied DNA Sciences's highest Cyclically Adjusted PS Ratio was 85.00. The lowest was 0.01. And the median was 5.21.

FRA:UDJ's Cyclically Adjusted PS Ratio is ranked better than
98.51% of 134 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.38 vs FRA:UDJ: 0.01

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Applied DNA Sciences's adjusted revenue per share data for the three months ended in Mar. 2024 was €0.983. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €125.00 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Applied DNA Sciences Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Applied DNA Sciences's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Applied DNA Sciences Cyclically Adjusted PS Ratio Chart

Applied DNA Sciences Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.06 0.96 0.69 0.15 0.17

Applied DNA Sciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.15 0.18 0.17 0.09 0.06

Competitive Comparison of Applied DNA Sciences's Cyclically Adjusted PS Ratio

For the Diagnostics & Research subindustry, Applied DNA Sciences's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Applied DNA Sciences's Cyclically Adjusted PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Applied DNA Sciences's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Applied DNA Sciences's Cyclically Adjusted PS Ratio falls into.



Applied DNA Sciences Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Applied DNA Sciences's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=4.66/125
=0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Applied DNA Sciences's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Applied DNA Sciences's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.983/131.7762*131.7762
=0.983

Current CPI (Mar. 2024) = 131.7762.

Applied DNA Sciences Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 36.412 100.560 47.715
201409 29.471 100.428 38.670
201412 53.000 99.070 70.497
201503 63.818 99.621 84.417
201506 74.852 100.684 97.967
201509 131.333 100.392 172.391
201512 43.393 99.792 57.301
201603 17.167 100.470 22.516
201606 19.367 101.688 25.097
201609 48.600 101.861 62.873
201612 26.750 101.863 34.606
201703 25.636 102.862 32.842
201706 48.455 103.349 61.783
201709 28.265 104.136 35.767
201712 15.657 104.011 19.837
201803 22.289 105.290 27.896
201806 22.895 106.317 28.378
201809 26.947 106.507 33.340
201812 20.447 105.998 25.420
201903 16.405 107.251 20.156
201906 37.854 108.070 46.158
201909 28.660 108.329 34.863
201912 4.798 108.420 5.832
202003 2.660 108.902 3.219
202006 1.677 108.767 2.032
202009 1.039 109.815 1.247
202012 4.864 109.897 5.832
202103 6.199 111.754 7.310
202106 3.898 114.631 4.481
202109 6.891 115.734 7.846
202112 9.858 117.630 11.044
202203 13.814 121.301 15.007
202206 9.051 125.017 9.540
202209 6.352 125.227 6.684
202212 7.702 125.222 8.105
202303 6.383 127.348 6.605
202306 4.174 128.729 4.273
202309 1.077 129.860 1.093
202312 1.194 129.419 1.216
202403 0.983 131.776 0.983

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Applied DNA Sciences  (FRA:UDJ) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Applied DNA Sciences Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Applied DNA Sciences's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Applied DNA Sciences (FRA:UDJ) Business Description

Traded in Other Exchanges
Address
50 Health Sciences Drive, Stony Brook, New York, NY, USA, 11790
Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) nd ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.

Applied DNA Sciences (FRA:UDJ) Headlines

No Headlines